دورية أكاديمية

Exploring a general multi-pronged activation strategy for natural product discovery in Actinomycetes.

التفاصيل البيبلوغرافية
العنوان: Exploring a general multi-pronged activation strategy for natural product discovery in Actinomycetes.
المؤلفون: Tay DWP; Institute of Sustainability for Chemicals, Energy and Environment (ISCE2), Agency for Science, Technology and Research (A*STAR), 8 Biomedical Grove, #07-01 Neuros Building, Singapore, 138665, Republic of Singapore., Tan LL; Molecular Engineering Lab, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, #07-06, Proteos, Singapore, 138673, Republic of Singapore., Heng E; Molecular Engineering Lab, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, #07-06, Proteos, Singapore, 138673, Republic of Singapore., Zulkarnain N; Molecular Engineering Lab, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, #07-06, Proteos, Singapore, 138673, Republic of Singapore., Ching KC; Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, #01-02, Nanos, Singapore, 138669, Republic of Singapore., Wibowo M; Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, #01-02, Nanos, Singapore, 138669, Republic of Singapore., Chin EJ; Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, #01-02, Nanos, Singapore, 138669, Republic of Singapore., Tan ZYQ; Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, #01-02, Nanos, Singapore, 138669, Republic of Singapore., Leong CY; Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, #01-02, Nanos, Singapore, 138669, Republic of Singapore., Ng VWP; Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, #01-02, Nanos, Singapore, 138669, Republic of Singapore., Yang LK; Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, #01-02, Nanos, Singapore, 138669, Republic of Singapore., Seow DCS; Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, #01-02, Nanos, Singapore, 138669, Republic of Singapore., Lim YW; Institute of Sustainability for Chemicals, Energy and Environment (ISCE2), Agency for Science, Technology and Research (A*STAR), 8 Biomedical Grove, #07-01 Neuros Building, Singapore, 138665, Republic of Singapore., Koh W; Bioinformatics Institute (BII), Agency of Science, Technology and Research (A*STAR), 30 Biopolis Street, #07-01, Matrix, Singapore, 138671, Republic of Singapore., Koduru L; Molecular Engineering Lab, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, #07-06, Proteos, Singapore, 138673, Republic of Singapore., Kanagasundaram Y; Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, #01-02, Nanos, Singapore, 138669, Republic of Singapore., Ng SB; Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, #01-02, Nanos, Singapore, 138669, Republic of Singapore., Lim YH; Institute of Sustainability for Chemicals, Energy and Environment (ISCE2), Agency for Science, Technology and Research (A*STAR), 8 Biomedical Grove, #07-01 Neuros Building, Singapore, 138665, Republic of Singapore. lim_yee_hwee@isce2.a-star.edu.sg.; Synthetic Biology Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, 10 Medical Drive, Singapore, 117597, Republic of Singapore. lim_yee_hwee@isce2.a-star.edu.sg., Wong FT; Institute of Sustainability for Chemicals, Energy and Environment (ISCE2), Agency for Science, Technology and Research (A*STAR), 8 Biomedical Grove, #07-01 Neuros Building, Singapore, 138665, Republic of Singapore. wongft@imcb.a-star.edu.sg.; Molecular Engineering Lab, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, #07-06, Proteos, Singapore, 138673, Republic of Singapore. wongft@imcb.a-star.edu.sg.
المصدر: Communications biology [Commun Biol] 2024 Jan 06; Vol. 7 (1), pp. 50. Date of Electronic Publication: 2024 Jan 06.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London, United Kingdom : Nature Publishing Group UK, [2018]-
مواضيع طبية MeSH: Actinobacteria* , Biological Products*/pharmacology, Actinomyces ; Anti-Bacterial Agents/pharmacology ; Computational Biology
مستخلص: Natural products possess significant therapeutic potential but remain underutilized despite advances in genomics and bioinformatics. While there are approaches to activate and upregulate natural product biosynthesis in both native and heterologous microbial strains, a comprehensive strategy to elicit production of natural products as well as a generalizable and efficient method to interrogate diverse native strains collection, remains lacking. Here, we explore a flexible and robust integrase-mediated multi-pronged activation approach to reliably perturb and globally trigger antibiotics production in actinobacteria. Across 54 actinobacterial strains, our approach yielded 124 distinct activator-strain combinations which consistently outperform wild type. Our approach expands accessible metabolite space by nearly two-fold and increases selected metabolite yields by up to >200-fold, enabling discovery of Gram-negative bioactivity in tetramic acid analogs. We envision these findings as a gateway towards a more streamlined, accelerated, and scalable strategy to unlock the full potential of Nature's chemical repertoire.
(© 2024. The Author(s).)
References: Synth Syst Biotechnol. 2017 Oct 21;2(4):276-286. (PMID: 29552652)
J Nat Prod. 2012 Mar 23;75(3):420-4. (PMID: 22288374)
J Antibiot (Tokyo). 1993 Jun;46(6):875-83. (PMID: 8344867)
J Antibiot (Tokyo). 2003 Feb;56(2):114-22. (PMID: 12715870)
mBio. 2012 Dec 11;3(6):. (PMID: 23232715)
Genetics. 2004 Apr;166(4):1775-82. (PMID: 15126397)
Nucleic Acids Res. 2022 Apr 8;50(6):3581-3592. (PMID: 35323947)
J Nat Prod. 2016 Mar 25;79(3):629-61. (PMID: 26852623)
Microb Cell Fact. 2023 Apr 28;22(1):84. (PMID: 37118806)
J Nat Prod. 2014 Jan 24;77(1):173-7. (PMID: 24422636)
mBio. 2020 Oct 20;11(5):. (PMID: 33082252)
Nat Biotechnol. 2012 Oct;30(10):918-20. (PMID: 23051804)
Appl Environ Microbiol. 2013 Jul;79(13):4159-63. (PMID: 23603676)
Biotechnol Bioeng. 2019 Feb;116(2):364-374. (PMID: 30345503)
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66. (PMID: 12136088)
Int J Mol Sci. 2021 Jul 15;22(14):. (PMID: 34299187)
Nat Chem Biol. 2017 Apr 10;:. (PMID: 28398287)
Nat Biotechnol. 2018 Jul 6;36(7):570-573. (PMID: 29979661)
Foods. 2021 Feb 02;10(2):. (PMID: 33540850)
J Nat Prod. 2019 May 24;82(5):1258-1263. (PMID: 30933507)
J Antibiot (Tokyo). 2013 Sep;66(9):549-54. (PMID: 23715038)
Acta Biochim Biophys Sin (Shanghai). 2008 Oct;40(10):877-82. (PMID: 18850053)
J Nat Prod. 2014 Nov 26;77(11):2537-44. (PMID: 25351193)
Appl Environ Microbiol. 2019 Mar 22;85(7):. (PMID: 30709825)
Nat Commun. 2022 Sep 6;13(1):5256. (PMID: 36068239)
J Antibiot (Tokyo). 2015 Jun;68(6):399-402. (PMID: 25627017)
J Antibiot (Tokyo). 2002 Oct;55(10):881-92. (PMID: 12523821)
J Org Chem. 2000 Oct 6;65(20):6412-7. (PMID: 11052082)
J Mol Biol. 2020 Jun 12;432(13):3950-3955. (PMID: 32339531)
Sci Adv. 2020 Jan 15;6(3):eaay5781. (PMID: 31998842)
Nucleic Acids Res. 2021 Jul 2;49(W1):W293-W296. (PMID: 33885785)
Nat Commun. 2019 Aug 26;10(1):3848. (PMID: 31451725)
Nat Commun. 2020 Nov 27;11(1):6058. (PMID: 33247171)
Org Biomol Chem. 2003 Feb 7;1(3):507-10. (PMID: 12926253)
Proc Natl Acad Sci U S A. 2021 Aug 3;118(31):. (PMID: 34326261)
Nat Commun. 2022 Apr 27;13(1):2266. (PMID: 35477578)
EMBO Rep. 2018 Nov;19(11):. (PMID: 30361392)
Antimicrob Agents Chemother. 2012 Jul;56(7):3657-63. (PMID: 22526318)
Plant Cell Rep. 2008 Dec;27(12):1821-31. (PMID: 18797873)
Biomolecules. 2021 Jan 30;11(2):. (PMID: 33573182)
Nat Chem Biol. 2007 Aug;3(8):480-5. (PMID: 17632514)
J Antibiot (Tokyo). 2002 Oct;55(10):873-80. (PMID: 12523820)
Nat Biotechnol. 2016 Aug 9;34(8):828-837. (PMID: 27504778)
ACS Chem Biol. 2020 Apr 17;15(4):1104-1114. (PMID: 32223208)
Antimicrob Agents Chemother. 2005 Jan;49(1):230-40. (PMID: 15616300)
Nat Biotechnol. 2020 Jan;38(1):76-83. (PMID: 31819261)
Mol Biol Evol. 2015 Jan;32(1):268-74. (PMID: 25371430)
J Appl Microbiol. 2022 Jan;132(1):59-77. (PMID: 34265147)
Cell. 2014 Jul 17;158(2):412-421. (PMID: 25036635)
Nat Microbiol. 2019 Dec;4(12):2498-2510. (PMID: 31611640)
Org Lett. 2002 Apr 4;4(7):1123-6. (PMID: 11922798)
Nat Commun. 2022 Oct 17;13(1):6135. (PMID: 36253467)
Cell. 2015 Dec 3;163(6):1297-300. (PMID: 26638061)
Sci Adv. 2018 Apr 11;4(4):eaar5459. (PMID: 29651464)
J Bacteriol. 2002 Oct;184(20):5746-52. (PMID: 12270833)
Bioinformatics. 2009 Aug 15;25(16):2078-9. (PMID: 19505943)
Appl Environ Microbiol. 2013 Jul;79(14):4484-92. (PMID: 23686264)
J Antibiot (Tokyo). 2014 Jul;67(7):527-31. (PMID: 24690911)
Front Microbiol. 2020 Feb 18;11:225. (PMID: 32132989)
Front Bioeng Biotechnol. 2021 Feb 18;9:632230. (PMID: 33681170)
J Antibiot (Tokyo). 2003 Oct;56(10):862-5. (PMID: 14700280)
Brief Bioinform. 2013 Mar;14(2):178-92. (PMID: 22517427)
Nat Rev Drug Discov. 2021 Mar;20(3):200-216. (PMID: 33510482)
Gene. 1992 Jul 1;116(1):43-9. (PMID: 1628843)
Nat Protoc. 2020 Aug;15(8):2470-2502. (PMID: 32651565)
Nucleic Acids Res. 2019 Jul 2;47(W1):W81-W87. (PMID: 31032519)
Mar Drugs. 2018 Jul 23;16(7):. (PMID: 30041461)
معلومات مُعتمدة: NRF-CRP19-2017-05-00 National Research Foundation Singapore (National Research Foundation-Prime Minister's office, Republic of Singapore); NRF-CRP19-2017-05-00 National Research Foundation Singapore (National Research Foundation-Prime Minister's office, Republic of Singapore); NRF-CRP19-2017-05-00 National Research Foundation Singapore (National Research Foundation-Prime Minister's office, Republic of Singapore); NRF-CRP19-2017-05-00 National Research Foundation Singapore (National Research Foundation-Prime Minister's office, Republic of Singapore); NRF-CRP19-2017-05-00 National Research Foundation Singapore (National Research Foundation-Prime Minister's office, Republic of Singapore); NRF-CRP19-2017-05-00 National Research Foundation Singapore (National Research Foundation-Prime Minister's office, Republic of Singapore); NRF-CRP19-2017-05-00 National Research Foundation Singapore (National Research Foundation-Prime Minister's office, Republic of Singapore); NRF-CRP19-2017-05-00 National Research Foundation Singapore (National Research Foundation-Prime Minister's office, Republic of Singapore); C211917006 Agency for Science, Technology and Research (A*STAR); C233017006 Agency for Science, Technology and Research (A*STAR); C211917003 Agency for Science, Technology and Research (A*STAR); C211917006 Agency for Science, Technology and Research (A*STAR); C233017006 Agency for Science, Technology and Research (A*STAR); C211917006 Agency for Science, Technology and Research (A*STAR)
المشرفين على المادة: 0 (Anti-Bacterial Agents)
0 (Biological Products)
تواريخ الأحداث: Date Created: 20240106 Date Completed: 20240108 Latest Revision: 20240202
رمز التحديث: 20240202
مُعرف محوري في PubMed: PMC10771470
DOI: 10.1038/s42003-023-05648-7
PMID: 38184720
قاعدة البيانات: MEDLINE
الوصف
تدمد:2399-3642
DOI:10.1038/s42003-023-05648-7